Cited by 13Neuroendocrine Tumor Research AdvancesPancreatic and Hepatic Oncology ResearchPancreatic function and diabetes

Synchronous Nesidioblastosis, Endocrine Microadenoma, and Intraductal Papillary Mucinous Neoplasia in a Man Presenting With Hyperinsulinemic Hypoglycemia

De Sousa, Sunita M.C., Haghighi, Koroush S., Qiu, Min Ru, Greenfield, Jerry R., Chen, Daniel L.T.·2016·Pancreas

Abstract

Herein, we report the first case of concomitant nesidioblastosis, pancreatic neuroendocrine tumor, and intraductal papillary mucinous neoplasia. The combination is significant as each of these pathological entities is independently very rare. The patient was a 33-year-old man who presented with symptomatic hyperinsulinemic hypoglycemia and no risk factors for pancreatic disease. Abdominal imaging showed an isolated 12 mm pancreatic lesion, whilst selective arterial calcium stimulation testing demonstrated multiple territories of insulin excess. He proceeded to subtotal pancreatectomy. Histopathology revealed an endocrine microadenoma, α and β cell nesidioblastosis, and multifocal intraductal papillary mucinous neoplasia. The endocrine microadenoma and nesidioblastosis stained for insulin, suggesting both likely contributed to hypoglycemia. Glucagon immunohistochemistry was also positive, though there were no clinical features of glucagon excess. Hypoglycemia resolved postoperatively. This case and other evidence from the literature suggest that hyperplasia and neoplasia may occur sequentially in the pancreas, and that endocrine and exocrine tumorigenesis may be linked in some individuals. Further study is required to identify a unifying mechanism, and to elucidate potential ramifications in the management of patients with pancreatic neoplasms.

Integrity signals

Registry

Crossref · 10.1097/mpa.0000000000000430

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

1 of the 31 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
De Sousa, S. M. C., Haghighi, K. S., Qiu, M. R., Greenfield, J. R., & Chen, D. L. T.
Affiliations
  • UNSW Sydney (AU)
  • St Vincent's Hospital Melbourne (AU)
  • Garvan Institute of Medical Research (AU)
Corresponding author
  • Greenfield, Jerry R.
  • Chen, Daniel L.T.
Venue
Pancreas
Published
2016-01
Volume
45
Issue
1
Pages
154-159
ISSN
0885-3177 (ISSN-L)
OpenAlex
W2411962594
Cited by
13
References
31
Citations by year
2025: 1 · 2024: 2 · 2023: 2 · 2022: 1 · 2020: 3 · 2019: 1 · 2018: 1 · 2017: 1 · 2016: 1
FWCI
0.79
Type
journal article
Language
en
Open access
closed
Locations
  • Pancreas (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Epidemiology › Neuroendocrine Tumor Research Advances
  • Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
  • Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
Keywords
nesidioblastosis, hyperinsulinemic hypoglycemia, pancreatic neuroendocrine tumors, subtotal pancreatectomy, insulin excess, pancreatic neoplasia
MeSH terms
Adenoma, Adult, Biopsy, Blood Glucose, Diagnosis, Differential, Humans, Hyperinsulinism, Hypoglycemia, Immunohistochemistry, Insulin, Male, Neoplasms, Multiple Primary, Pancreatic Function Tests, Pancreatic Neoplasms, Predictive Value of Tests, Risk Factors, Time Factors, Tomography, X-Ray Computed, Treatment Outcome, Neoplasms, Cystic, Mucinous, and Serous, Neuroendocrine Tumors, Nesidioblastosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review